Off-label drug use in China after the Physician Law (2021): legal challenges and solutions
From a legal doctrinal perspective, the article concludes by elaborating on how each legal requirement should be met. Our research provides insights into the factors that lead to legal liability for off-label drug use and examines how physicians and medical institutions can avoid such liability.
Authors
- Shengnan Liang (ORCID: https://orcid.org/0000-0002-9667-256X)
- Feng Cai (ORCID: https://orcid.org/0000-0002-6810-7627)
Institutions
- Shanghai University of Finance and Economics (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-14
- DOI
- https://doi.org/10.3389/fphar.2025.1547418
- Citations
- 1
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 3.49
Funders
- Shanghai University of Finance and Economics
- Fundamental Research Funds for the Central Universities